Cargando…
Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181081/ https://www.ncbi.nlm.nih.gov/pubmed/35683411 http://dx.doi.org/10.3390/jcm11113024 |
_version_ | 1784723679664406528 |
---|---|
author | Lasica, Ratko Djukanovic, Lazar Mrdovic, Igor Savic, Lidija Ristic, Arsen Zdravkovic, Marija Simic, Dragan Krljanac, Gordana Popovic, Dejana Simeunovic, Dejan Rajic, Dubravka Asanin, Milika |
author_facet | Lasica, Ratko Djukanovic, Lazar Mrdovic, Igor Savic, Lidija Ristic, Arsen Zdravkovic, Marija Simic, Dragan Krljanac, Gordana Popovic, Dejana Simeunovic, Dejan Rajic, Dubravka Asanin, Milika |
author_sort | Lasica, Ratko |
collection | PubMed |
description | The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between 7–36%. There is growing evidence of the incidence of acute coronary syndrome (ACS) in COVID-19, both due to coronary artery thrombosis and insufficient oxygen supply to the myocardium in conditions of an increased need. The diagnosis and treatment of patients with COVID-19 and acute myocardial infarction (AMI) is a major challenge for physicians. Often the presence of mixed symptoms, due to the combined presence of COVID-19 and ACS, as well as possible other diseases, nonspecific changes in the electrocardiogram (ECG), and often elevated serum troponin (cTn), create dilemmas in diagnosing ACS in COVID-19. Given the often-high ischemic risk, as well as the risk of bleeding, in these patients and analyzing the benefit/risk ratio, the treatment of patients with AMI and COVID-19 is often associated with dilemmas and difficult decisions. Due to delays in the application of the therapeutic regimen, complications of AMI are more common, and the mortality rate is higher. |
format | Online Article Text |
id | pubmed-9181081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91810812022-06-10 Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era Lasica, Ratko Djukanovic, Lazar Mrdovic, Igor Savic, Lidija Ristic, Arsen Zdravkovic, Marija Simic, Dragan Krljanac, Gordana Popovic, Dejana Simeunovic, Dejan Rajic, Dubravka Asanin, Milika J Clin Med Review The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between 7–36%. There is growing evidence of the incidence of acute coronary syndrome (ACS) in COVID-19, both due to coronary artery thrombosis and insufficient oxygen supply to the myocardium in conditions of an increased need. The diagnosis and treatment of patients with COVID-19 and acute myocardial infarction (AMI) is a major challenge for physicians. Often the presence of mixed symptoms, due to the combined presence of COVID-19 and ACS, as well as possible other diseases, nonspecific changes in the electrocardiogram (ECG), and often elevated serum troponin (cTn), create dilemmas in diagnosing ACS in COVID-19. Given the often-high ischemic risk, as well as the risk of bleeding, in these patients and analyzing the benefit/risk ratio, the treatment of patients with AMI and COVID-19 is often associated with dilemmas and difficult decisions. Due to delays in the application of the therapeutic regimen, complications of AMI are more common, and the mortality rate is higher. MDPI 2022-05-27 /pmc/articles/PMC9181081/ /pubmed/35683411 http://dx.doi.org/10.3390/jcm11113024 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lasica, Ratko Djukanovic, Lazar Mrdovic, Igor Savic, Lidija Ristic, Arsen Zdravkovic, Marija Simic, Dragan Krljanac, Gordana Popovic, Dejana Simeunovic, Dejan Rajic, Dubravka Asanin, Milika Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era |
title | Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era |
title_full | Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era |
title_fullStr | Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era |
title_full_unstemmed | Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era |
title_short | Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era |
title_sort | acute coronary syndrome in the covid-19 era—differences and dilemmas compared to the pre-covid-19 era |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181081/ https://www.ncbi.nlm.nih.gov/pubmed/35683411 http://dx.doi.org/10.3390/jcm11113024 |
work_keys_str_mv | AT lasicaratko acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT djukanoviclazar acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT mrdovicigor acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT saviclidija acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT risticarsen acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT zdravkovicmarija acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT simicdragan acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT krljanacgordana acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT popovicdejana acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT simeunovicdejan acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT rajicdubravka acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era AT asaninmilika acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era |